- Monday, May 18, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global NGS Sample Preparation Market by Product (Reagent & Consumables, and NGS Workstations), By Workflow (Library Preparation [DNA, RNA], Target Enrichment (Targeted Sequencing, Whole Exome Sequencing and Others) and Quality Control), By Technology (Sequencing By Synthesis (Sbs), Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing (Smrt), Nanopore Sequencing and Others), By Application (Diagonsis(Infectious Disease, Cancer Diagnostics and Reproductive Health Diagnostics), Drug Discovery, Agricultural & Animal Research, and Others),By End-User(Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Global NGS Sample Preparation Market Overview
Global NGS Sample Preparation Market is estimated to reach USD 9.12 billion by 2030, growing at a CAGR of 11.45% during the forecast period of 2022-2030. It was valued at USD 3.56 billion in 2022. NGS is also known as high-throughput sequencing and can be used to indicate a range of gene sequencing technologies that can improve the original Sanger sequencing process. In addition to reducing the cost and time of DNA and RNA sequencing, next-generation sequencing can also sequence smaller samples. Sample preparation is a new highlight in NGS. New reagents and instruments are constantly emerging to reduce time and increase throughput. At the same time, new methods are continually being developed to process fewer samples, such as single cells.Global NGS Sample Preparation Market Insights
The increasing awareness about precision medicine and the high incidence of chronic diseases are expected to propel the global NGS sample preparation market in the upcoming years. Moreover, the upsurge in the adoption of genomics for developing innovative diagnostic tools and tests and the development of precision & personalized medicines will accelerate the growth of global NGS sample preparation market size in the estimated periods. Additionally, technological advancements in the field of NGS sample preparation have led to the availability of standardized sample preparation protocols that are driving the growth of the NGS sample preparation industry. Furthermore, the rising prevalence of chronic disorders such as cancer, diabetes, inflammatory bowel disease, and autoimmune diseases has led to the demand for NGS sample preparation inn the expected periods. In addition, the evolution of integrated and automated informatics and mechanical protocols have brought about automation in NGS sample preparation such as it enhances sequencing speed & capacity, and sample tracking. The growing need for personalized treatment coupled with the surge in healthcare spending and improvement in healthcare technology is projected, driving the growth of the NGS sample preparation market.Growth Driver
The surge in demand for NGS in Precision Medicine and Molecular Diagnostics
The development of DNA and RNA sequencing technologies has accelerated the understanding of molecular characteristics of genetic diseases. The application of high-throughput sequencing, that is, next-generation sequencing (NGS) technology to detect the genetic characteristics of diseases. The rapid development of NGS technology has also accelerated the widespread application of this technology in clinical molecular diagnosis. According to different detection purposes, the clinical application of NGS technology is mainly divided into the following two strategies: designing appropriate chips for diseases of known etiology, and directly targeted genome sequencing of multiple known disease-causing genes and sequencing exomes or whole genomes for diseases of unknown etiology. The most widespread application of targeted genome sequencing in clinical diagnosis is for the clinical diagnosis and treatment of cancer subtypes.Product Type Segmental Analysis
Based on product type, the global NGS Sample Preparation market categorized into Reagent & Consumables and NGS Workstations. The Reagent & Consumables segment witness to gain a major share in the market by 2030, attributable to these is deep well plates, pipettes, tips, high precision, and highly efficient during experiments. The NGS Workstations segment will drive due to the increasing efficiency and reducing hands-on time and flexibility to maximize scheduling.Workflow Segmental Analysis
Based on workflow, the global NGS Sample Preparation market classified into Library Preparation [DNA, RNA], Target Enrichment (Targeted Sequencing, Whole Exome Sequencing, and Others), and Quality Control. The Library Preparation segment accounted for a higher revenue share in 2021, and it will grow substantially in the coming years. It is attributed to their help in generating a collection of DNA fragments for sequencing and used for ligation of barcoded molecular adaptors, end repair, and purification reactions. The Target Enrichment will grow in the forecast periods due to its ability to process hundreds of millions of DNA templates in parallel. It includes Targeted Sequencing and Whole Exome Sequencing.Technology Segmental Analysis
Based on technology, the global NGS Sample Preparation market classified into Sequencing by Synthesis (Sbs), Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing (Smrt), Nanopore Sequencing, and Others. The Sequencing by Synthesis (Sbs) estimated to generate maximum revenue by 2030, on account of the sequencing by synthesis, helps in analyzing DNA quickly, accurately, and proves to be a cost-effective option and sequenced the entire human genome in few hours. The Ion Semiconductor Sequencing will grow due to its help in DNA sequencing for the detection of hydrogen ions and enables to directly convert chemically encoded information into digital information on the semiconductor chip.Application Segmental Analysis
Based on application, the global NGS Sample Preparation market categorized into Diagnosis (Infectious Disease, Cancer Diagnostics, and Reproductive Health Diagnostics), Drug Discovery, Agricultural & Animal Research, and Others. Diagnosis segment expected to gain higher market share by 2030 owing to the increasing number of new cancer cases worldwide, and the surge in demand for new product development for cancer and NIPT.End-User Industry Segmental Analysis
Based on the end-user industry, the global NGS Sample Preparation market categorized into Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others. Academic Institutes & Research Centers segment expected to dominate the market by 2030 on account of the rising collaborations between NGS market players and academic & research institutions, and favorable funding scenario for genomics research. Hospitals & Clinics segment will surge by the availability of upgraded third-generation sequencing technologies that facilitates diagnostic procedures.Region Segmental Analysis
Based on geography, the global NGS Sample Preparation market size segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2030, owing to the swelling NGS-based research & clinical applications in the region and favorable initiatives by government and private bodies for the development and adoption of NGS technologies. The Asia Pacific will drive due to the rising preference for personalized medicine coupled with development in NGS bioinformatics and pre-sequencing solutions.Competitor Analysis
Companies such as Illumina Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Pacific Biosciences of California, PerkinElmer Inc., F. Hoffmann-La Roche, New England Biolabs, Inc., and NuGEN Technologies, Inc. are the key players in the global NGS Sample Preparation Market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global NGS Sample Preparation manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to NGS Sample Preparation
- Regulatory bodies
Scope of the report
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 1.56 Billion |
| Revenue forecast in 2027 | USD 5.12 Billion |
| Growth Rate | CAGR of 18.45% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | Illumina Inc., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Thermo Fisher Scientific, QIAGEN N.V., Pacific Biosciences of California, PerkinElmer Inc., F. Hoffmann-La Roche, New England Biolabs, Inc., and NuGEN Technologies, Inc. |
Recent Developments
- In September 2022, Illumina Inc. established its next-generation NovaSeq X systems, which can develop more than 20,000 whole genomes per year or 2.5 times that of prior sequencers.
- In September 2021, Illumina partnered with Merck to develop and commercialize collaborative clinical and research tests to identify cancer mutations.
- In August 2021, QIAGEN Signed a Collaborative Diagnostics (CDx) agreement with OncXerna Therapeutics, Inc. to develop a non-exclusive license for the NGS CDx and Xerna™ TME Panel OncXerna’s product candidate, Navicixizumab.
- In August 2021, QIAGEN Collaborated with GT Molecular to offer a complete SARS-CoV-2 wastewater detection solution based on QIAcuity digital PCR Technology.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product- Reagent & Consumables
- Workstations
- Library Preparation
- DNA
- RNA
- Target Enrichment
- Targeted Sequencing
- Whole Exome Sequencing
- Others
- Quality Control
- Sequencing By Synthesis (Sbs)
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing (Smrt)
- Nanopore Sequencing
- Others
- Diagonsis
- Infectious Disease
- Cancer Diagnostics
- Reproductive Health Diagnostics
- Drug Discovery,
- Agricultural & Animal Research
- Others
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Multi-Vendor IT Support Service Market
Parental Control Software Market
Global Cannabis Testing Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global NGS Sample Preparation Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Product
5.2.1.1. Reagent & Consumables
5.2.1.2. Workstations
5.2.2. By Workflow
5.2.2.1. Library Preparation
5.2.2.1.1. DNA
5.2.2.1.2. RNA
5.2.2.2. Target Enrichment
5.2.2.2.1. Targeted Sequencing
5.2.2.2.2. Whole Exome Sequencing
5.2.2.2.3. Others
5.2.2.3. Quality Control
5.2.3. By Technology
5.2.3.1. Sequencing By Synthesis (Sbs)
5.2.3.2. Ion Semiconductor Sequencing
5.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
5.2.3.4. Nanopore Sequencing
5.2.3.5. Others
5.2.4. By Application
5.2.4.1. Diagnosis
5.2.4.1.1. Infectious Disease
5.2.4.1.2. Cancer Diagnostics
5.2.4.1.3. Reproductive Health Diagnostics
5.2.4.2. Drug Discovery,
5.2.4.3. Agricultural & Animal Research
5.2.4.4. Others
5.2.5. By End-User
5.2.5.1. Academic Institutes & Research Centers
5.2.5.2. Hospitals & Clinics
5.2.5.3. Pharmaceutical & Biotechnology Companies
5.2.5.4. Others
5.2.6. By Region
5.2.6.1. North America
5.2.6.2. Europe
5.2.6.3. Asia-Pacific
5.2.6.4. South America
5.2.6.5. The Middle East & Africa
- North America NGS Sample Preparation Market Overview
6.1. North America NGS Sample Preparation Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Product
6.2.1.1. Reagent & Consumables
6.2.1.2. Workstations
6.2.2. By Workflow
6.2.2.1. Library Preparation
6.2.2.1.1. DNA
6.2.2.1.2. RNA
6.2.2.2. Target Enrichment
6.2.2.2.1. Targeted Sequencing
6.2.2.2.2. Whole Exome Sequencing
6.2.2.2.3. Others
6.2.2.3. Quality Control
6.2.3. By Technology
6.2.3.1. Sequencing By Synthesis (Sbs)
6.2.3.2. Ion Semiconductor Sequencing
6.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
6.2.3.4. Nanopore Sequencing
6.2.3.5. Others
6.2.4. By Application
6.2.4.1. Diagnosis
6.2.4.1.1. Infectious Disease
6.2.4.1.2. Cancer Diagnostics
6.2.4.1.3. Reproductive Health Diagnostics
6.2.4.2. Drug Discovery,
6.2.4.3. Agricultural & Animal Research
6.2.4.4. Others
6.2.5. By End-User
6.2.5.1. Academic Institutes & Research Centers
6.2.5.2. Hospitals & Clinics
6.2.5.3. Pharmaceutical & Biotechnology Companies
6.2.5.4. Others
6.2.6. By Country
6.2.6.1. US
6.2.6.2. Canada
6.2.6.3. Mexico
6.2.7. Company Market Share (Top 3-5)
6.2.8. Economic Impact Study on North America NGS Sample Preparation Market
- Europe NGS Sample Preparation Market Overview
7.1. Europe NGS Sample Preparation Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Product
7.2.1.1. Reagent & Consumables
7.2.1.2. Workstations
7.2.2. By Workflow
7.2.2.1. Library Preparation
7.2.2.1.1. DNA
7.2.2.1.2. RNA
7.2.2.2. Target Enrichment
7.2.2.2.1. Targeted Sequencing
7.2.2.2.2. Whole Exome Sequencing
7.2.2.2.3. Others
7.2.2.3. Quality Control
7.2.3. By Technology
7.2.3.1. Sequencing By Synthesis (Sbs)
7.2.3.2. Ion Semiconductor Sequencing
7.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
7.2.3.4. Nanopore Sequencing
7.2.3.5. Others
7.2.4. By Application
7.2.4.1. Diagnosis
7.2.4.1.1. Infectious Disease
7.2.4.1.2. Cancer Diagnostics
7.2.4.1.3. Reproductive Health Diagnostics
7.2.4.2. Drug Discovery,
7.2.4.3. Agricultural & Animal Research
7.2.4.4. Others
7.2.5. By End-User
7.2.5.1. Academic Institutes & Research Centers
7.2.5.2. Hospitals & Clinics
7.2.5.3. Pharmaceutical & Biotechnology Companies
7.2.5.4. Others
7.2.6. By Country
7.2.6.1. Germany
7.2.6.2. UK
7.2.6.3. France
7.2.6.4. Italy
7.2.6.5. Rest of Europe
7.2.7. Company Market Share (Top 3-5)
7.2.8. Economic Impact Study on Europe NGS Sample Preparation Market
- Asia-Pacific NGS Sample Preparation Market Overview
8.1. Asia-Pacific NGS Sample Preparation Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Product
8.2.1.1. Reagent & Consumables
8.2.1.2. Workstations
8.2.2. By Workflow
8.2.2.1. Library Preparation
8.2.2.1.1. DNA
8.2.2.1.2. RNA
8.2.2.2. Target Enrichment
8.2.2.2.1. Targeted Sequencing
8.2.2.2.2. Whole Exome Sequencing
8.2.2.2.3. Others
8.2.2.3. Quality Control
8.2.3. By Technology
8.2.3.1. Sequencing By Synthesis (Sbs)
8.2.3.2. Ion Semiconductor Sequencing
8.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
8.2.3.4. Nanopore Sequencing
8.2.3.5. Others
8.2.4. By Application
8.2.4.1. Diagnosis
8.2.4.1.1. Infectious Disease
8.2.4.1.2. Cancer Diagnostics
8.2.4.1.3. Reproductive Health Diagnostics
8.2.4.2. Drug Discovery,
8.2.4.3. Agricultural & Animal Research
8.2.4.4. Others
8.2.5. By End-User
8.2.5.1. Academic Institutes & Research Centers
8.2.5.2. Hospitals & Clinics
8.2.5.3. Pharmaceutical & Biotechnology Companies
8.2.5.4. Others
8.2.6. By Country
8.2.6.1. India
8.2.6.2. Japan
8.2.6.3. Australia
8.2.6.4. Rest of Asia Pacific
8.2.7. Company Market Share (Top 3-5)
8.2.8. Economic Impact Study on Asia Pacific NGS Sample Preparation Market
- South America NGS Sample Preparation Market Overview
9.1. South America NGS Sample Preparation Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Product
9.2.1.1. Reagent & Consumables
9.2.1.2. Workstations
9.2.2. By Workflow
9.2.2.1. Library Preparation
9.2.2.1.1. DNA
9.2.2.1.2. RNA
9.2.2.2. Target Enrichment
9.2.2.2.1. Targeted Sequencing
9.2.2.2.2. Whole Exome Sequencing
9.2.2.2.3. Others
9.2.2.3. Quality Control
9.2.3. By Technology
9.2.3.1. Sequencing By Synthesis (Sbs)
9.2.3.2. Ion Semiconductor Sequencing
9.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
9.2.3.4. Nanopore Sequencing
9.2.3.5. Others
9.2.4. By Application
9.2.4.1. Diagnosis
9.2.4.1.1. Infectious Disease
9.2.4.1.2. Cancer Diagnostics
9.2.4.1.3. Reproductive Health Diagnostics
9.2.4.2. Drug Discovery,
9.2.4.3. Agricultural & Animal Research
9.2.4.4. Others
9.2.5. By End-User
9.2.5.1. Academic Institutes & Research Centers
9.2.5.2. Hospitals & Clinics
9.2.5.3. Pharmaceutical & Biotechnology Companies
9.2.5.4. Others
9.2.6. By Country
9.2.6.1. Brazil
9.2.6.2. Argentina
9.2.6.3. Rest of South America
9.2.7. Company Market Share (Top 3-5)
9.2.8. Economic Impact Study on South America NGS Sample Preparation Market
- The Middle East & Africa NGS Sample Preparation Market Overview
10.1. The Middle East & Africa NGS Sample Preparation Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Product
10.2.1.1. Reagent & Consumables
10.2.1.2. Workstations
10.2.2. By Workflow
10.2.2.1. Library Preparation
10.2.2.1.1. DNA
10.2.2.1.2. RNA
10.2.2.2. Target Enrichment
10.2.2.2.1. Targeted Sequencing
10.2.2.2.2. Whole Exome Sequencing
10.2.2.2.3. Others
10.2.2.3. Quality Control
10.2.3. By Technology
10.2.3.1. Sequencing By Synthesis (Sbs)
10.2.3.2. Ion Semiconductor Sequencing
10.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
10.2.3.4. Nanopore Sequencing
10.2.3.5. Others
10.2.4. By Application
10.2.4.1. Diagnosis
10.2.4.1.1. Infectious Disease
10.2.4.1.2. Cancer Diagnostics
10.2.4.1.3. Reproductive Health Diagnostics
10.2.4.2. Drug Discovery,
10.2.4.3. Agricultural & Animal Research
10.2.4.4. Others
10.2.5. By End-User
10.2.5.1. Academic Institutes & Research Centers
10.2.5.2. Hospitals & Clinics
10.2.5.3. Pharmaceutical & Biotechnology Companies
10.2.5.4. Others
10.2.6. By Country
10.2.6.1. Saudi Arabia
10.2.6.2. UAE
10.2.6.3. South Africa
10.2.6.4. Rest of the Middle East & Africa
10.2.7. Company Market Share (Top 3-5)
10.2.8. Economic Impact Study on Middle East & Africa NGS Sample Preparation Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Illumina Inc.
11.7.2. Thermo Fisher Scientific
11.7.3. QIAGEN N.V.
11.7.4. Agilent Technologies, Inc.
11.7.5. Beckman Coulter
11.7.6. Becton
11.7.7. Dickinson and Company
11.7.8. Pacific Biosciences of California
11.7.9. PerkinElmer Inc.
11.7.10. Hoffmann-La Roche
11.7.11. New England Biolabs, Inc.
11.7.12. NuGEN Technologies
11.7.13. Other Prominent Players
Frequently Asked Questions (FAQ):
The growth rate of the Global NGS Sample Preparation Market is 11.45% from 2022 to 2030.
Global NGS Sample Preparation Market is estimated to reach USD 9.12 billion by 2030, and It was valued at USD 3.56 billion in 2022.
The high incidence of chronic diseases and increasing awareness about precision medicine are the growth drivers of the Global NGS Sample Preparation Market.
Biotechnology and Pharmaceutical Companies, Hospitals & Clinics, Academic Institutes & Research Centers, and Others are the end-users of the NGS Sample Preparation Market products.
Illumina Inc., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Thermo Fisher Scientific, QIAGEN N.V., Pacific Biosciences of California, PerkinElmer Inc., F. Hoffmann-La Roche, New England Biolabs, Inc., and NuGEN Technologies, Inc. are the key players in the global NGS Sample Preparation Market.
